GLYZIMAC 40 TABLET

Product Description

GLYZIMAC 40 TABLET is a trusted oral anti-diabetic medication containing Gliclazide 40mg, formulated to effectively manage Type 2 Diabetes Mellitus by improving glycemic control. As a second-generation sulfonylurea, it promotes insulin secretion, making it ideal for patients requiring stable blood sugar regulation.

Manufactured in WHO-GMP certified facilities, GLYZIMAC 40 is a reliable choice for diabetologists, hospital pharmacies, and B2B pharmaceutical distributors seeking a high-demand anti-diabetic tablet with proven efficacy and patient compliance.

Key Benefits:

• Contains Gliclazide 40mg for effective blood glucose control

• Supports long-term management of Type 2 Diabetes

• Minimizes the risk of hypoglycemia and promotes vascular protection

• Ensures consistent performance with quality-assured manufacturing

Applications:

• Used in the treatment of Type 2 Diabetes Mellitus

• Helps in reducing fasting and postprandial blood sugar levels

• Suitable for monotherapy or as part of a combination regimen